Harrell Investment Partners, LLC Amgen Inc Transaction History

Harrell Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $2.76 Million - $3.06 Million	-11,811 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $238,997 - $278,512	1,077 Added 10.03%	11,811 $2.94 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $429,514 - $511,474	-1,985 Reduced 15.61%	10,734 $2.47 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $5,396 - $6,001	23 Added 0.18%	12,719 $3.23 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $2.51 Million - $3.08 Million	12,696 New	12,696 $2.99 Million

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Harrell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Harrell Investment Partners, LLC with notifications on news.